Why should duloxetine be avoided in people with stiff person syndrome?

Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff person syndrome

Benavides DR, Newsome SD.

Neurol Neuroimmunol Neuroinflamm 2016; 3:e281.

Stiff-person syndrome (SPS) is a neuroimmunologic disorder characterized by painful spasms and muscle rigidity attributed to impaired inhibitory γ-aminobutyric acid (GABA) descending pathways.The immunopathogenesis remains unknown and the pathogenic significance of antibodies against glutamic acid decarboxylase (GAD) is controversial.

Herein, we report 4 cases of anti-GAD65-positive patients with SPS  who had significant worsening of symptoms and disability with the serotonin-norepinephrine reuptake inhibitor (SNRI) duloxetine. While causation cannot be proven, these observations suggest the importance of investigating the relationship between SNRI use and SPS clinical exacerbations.

This reference is now included in the neurochecklist:

Stiff person syndrome (SPS): clinical features

By Fuse809 (talk) - Own work, Public Domain, Link
By Fuse809 (talk) – Own work, Public Domain, Link

 

Advertisements

3 thoughts on “Why should duloxetine be avoided in people with stiff person syndrome?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s